Method of delaying the onset of clinically definite multiple sclerosis

Details for Australian Patent Application No. 2008330093 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Stark, Yafit; Ladkani, David

Agent FB Rice

Pub. Number AU-A-2008330093

PCT Pub. Number WO2009/070298

Priority 61/005,271 03.12.07 US; 61/192,455 17.09.08 US; 61/004,710 28.11.07 US; 61/007,141 11.12.07 US

Filing date 26 November 2008

Wipo publication date 4 June 2009

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/070298 Priority application(s): WO2009/070298

14 April 2011 Assignment before Grant

  Teva Pharmaceutical Industries, Ltd. The application has been assigned to Yeda Research and Development Co., Ltd. Assignments before Grant, Section 113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008330098-System and method for receiving analog and digital input

2008330090-Payload control system based on force and speed